Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × toripalimab × Clear all

NCT04918186 2026-02-12

IPROC

Phase 2 Recruiting

Ovarian Neoplasms

NCT05342506 2022-04-22

Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies

Phase 2 Unknown

Uterine Cervical Neoplasms, Ovarian Neoplasms